ICU predictive factors of fibrotic changes following COVID-19 related ARDS: a RECOVIDS substudy.

Summary

In a 32-center prospective cohort of COVID-19 ARDS survivors, 36.8% showed fibrotic lung changes at 6 months. A nomogram incorporating clinical and imaging predictors achieved an AUC of 80.6%, supporting risk stratification and targeted follow-up.

Key Findings

• Among 440 analyzed survivors, 162 (36.8%) had fibrotic changes at 6 months post-ICU discharge.
• Independent predictors included older age, BMI <30, Charlson comorbidity index ≥1, invasive mechanical ventilation, early signs of fibrosis, and greater baseline CT involvement.
• The nomogram predicting pulmonary fibrotic changes achieved an AUC of 80.6% (95% CI 76.4–84.8).
• Late organizing pneumonia was the most common pattern; 18.5% of FC cases showed anterior fibrosis compatible with post-ventilatory changes.

Clinical Implications

Use the identified predictors to triage survivors for imaging follow-up and rehab, and to anticipate anterior ventilation-related fibrosis patterns in those requiring invasive ventilation.

Limitations

• Observational design limits causal inference
• External validation beyond the study cohort is not reported in the abstract

Future Directions

External validation of the nomogram, integration with lung function trajectories, and testing interventions guided by early risk stratification.